AC Immune (ACIU) Shares Issued (2020 - 2021)
AC Immune's (ACIU) quarterly Shares Issued came in at $13.7 million in Q4 2021, up 22.55% year-on-year from $11.2 million in Q4 2020, and up 22.55% on a QoQ basis from $11.2 million in Q4 2020.
AC Immune (ACIU) Shares Issued (2020 - 2021) Analysis & Trends
AC Immune (ACIU) has 2 years of Shares Issued data on file, last reported at $13.7 million in Q4 2021.
- On a quarterly basis, Shares Issued rose 22.55% year-over-year to $13.7 million in Q4 2021; TTM through Dec 2021 was $13.7 million, a 22.55% increase from a year earlier, with the FY2021 full-year figure at $13.9 million, up 23.66% from the prior year.
- Shares Issued for Q4 2021 stood at $13.7 million, up from $11.2 million in the prior quarter.
- Over the last five years, Shares Issued for ACIU reached as high as $13.7 million in Q4 2021 and fell as low as $11.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 19.44 Mn |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2021 | 13.74 Mn |
| Dec 31, 2020 | 11.21 Mn |
| Dec 31, 2020 | 11.21 Mn |